These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 16448692)

  • 21. Improved and automated prediction of effective siRNA.
    Chalk AM; Wahlestedt C; Sonnhammer EL
    Biochem Biophys Res Commun; 2004 Jun; 319(1):264-74. PubMed ID: 15158471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stat3 as a molecular target in RNA interference-based treatment of oral squamous cell carcinoma.
    Klosek SK; Nakashiro K; Hara S; Goda H; Hamakawa H
    Oncol Rep; 2008 Oct; 20(4):873-8. PubMed ID: 18813829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. On the art of identifying effective and specific siRNAs.
    Pei Y; Tuschl T
    Nat Methods; 2006 Sep; 3(9):670-6. PubMed ID: 16929310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of target site accessibility on the design of effective siRNAs.
    Tafer H; Ameres SL; Obernosterer G; Gebeshuber CA; Schroeder R; Martinez J; Hofacker IL
    Nat Biotechnol; 2008 May; 26(5):578-83. PubMed ID: 18438400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of human metapneumovirus replication by small interfering RNA.
    Deffrasnes C; Cavanagh MH; Goyette N; Cui K; Ge Q; Seth S; Templin MV; Quay SC; Johnson PH; Boivin G
    Antivir Ther; 2008; 13(6):821-32. PubMed ID: 18839783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A low molecular weight fraction of polyethylenimine (PEI) displays increased transfection efficiency of DNA and siRNA in fresh or lyophilized complexes.
    Werth S; Urban-Klein B; Dai L; Höbel S; Grzelinski M; Bakowsky U; Czubayko F; Aigner A
    J Control Release; 2006 May; 112(2):257-70. PubMed ID: 16574264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. siRNA and shRNA as anticancer agents in a cervical cancer model.
    Gu W; Putral L; McMillan N
    Methods Mol Biol; 2008; 442():159-72. PubMed ID: 18369785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Soft computing model for optimized siRNA design by identifying off target possibilities using artificial neural network model.
    Murali R; John PG; Peter S D
    Gene; 2015 May; 562(2):152-8. PubMed ID: 25725126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selecting effective siRNA sequences based on the self-organizing map and statistical techniques.
    Takasaki S; Kawamura Y; Konagaya A
    Comput Biol Chem; 2006 Jun; 30(3):169-78. PubMed ID: 16600687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene silencing with siRNA targeting E6/E7 as a therapeutic intervention in a mouse model of cervical cancer.
    Jonson AL; Rogers LM; Ramakrishnan S; Downs LS
    Gynecol Oncol; 2008 Nov; 111(2):356-64. PubMed ID: 18755502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrated siRNA design based on surveying of features associated with high RNAi effectiveness.
    Gong W; Ren Y; Xu Q; Wang Y; Lin D; Zhou H; Li T
    BMC Bioinformatics; 2006 Nov; 7():516. PubMed ID: 17129386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune activation by siRNA/liposome complexes in mice is sequence- independent: lack of a role for Toll-like receptor 3 signaling.
    Kim JY; Choung S; Lee EJ; Kim YJ; Choi YC
    Mol Cells; 2007 Oct; 24(2):247-54. PubMed ID: 17978578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. sIR: siRNA Information Resource, a web-based tool for siRNA sequence design and analysis and an open access siRNA database.
    Shah JK; Garner HR; White MA; Shames DS; Minna JD
    BMC Bioinformatics; 2007 May; 8():178. PubMed ID: 17540034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of siRNA nuclease stability on the in vitro and in vivo kinetics of siRNA-mediated gene silencing.
    Bartlett DW; Davis ME
    Biotechnol Bioeng; 2007 Jul; 97(4):909-21. PubMed ID: 17154307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Silencing of c-myc gene expression by enzymatically and chemically synthesized siRNAs].
    Kabilova TO; Vladimirova AV; Repkova MN; Ven'iaminova AG; Chernolovskaia EL; Vlasov VV
    Mol Biol (Mosk); 2006; 40(6):1037-46. PubMed ID: 17209432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a novel nonviral gene silencing system that is effective both in vitro and in vivo by using a star-shaped block copolymer (star vector).
    Mori T; Ishikawa A; Nemoto Y; Kambe N; Sakamoto M; Nakayama Y
    Bioconjug Chem; 2009 Jun; 20(6):1262-9. PubMed ID: 19456093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Competition potency of siRNA is specified by the 5'-half sequence of the guide strand.
    Yoo JW; Kim S; Lee DK
    Biochem Biophys Res Commun; 2008 Feb; 367(1):78-83. PubMed ID: 18164261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel program to design siRNAs simultaneously effective to highly variable virus genomes.
    Lee HS; Ahn J; Jun EJ; Yang S; Joo CH; Kim YK; Lee H
    Biochem Biophys Res Commun; 2009 Jul; 384(4):431-5. PubMed ID: 19422797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyaluronic acid complexed to biodegradable poly L-arginine for targeted delivery of siRNAs.
    Kim EJ; Shim G; Kim K; Kwon IC; Oh YK; Shim CK
    J Gene Med; 2009 Sep; 11(9):791-803. PubMed ID: 19569085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene expression silencing with 'specific' small interfering RNA goes beyond specificity - a study of key parameters to take into account in the onset of small interfering RNA off-target effects.
    Vankoningsloo S; de Longueville F; Evrard S; Rahier P; Houbion A; Fattaccioli A; Gastellier M; Remacle J; Raes M; Renard P; Arnould T
    FEBS J; 2008 Jun; 275(11):2738-53. PubMed ID: 18422646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.